"Warfarin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
Descriptor ID |
D014859
|
MeSH Number(s) |
D03.383.663.283.446.520.914 D03.633.100.150.446.520.914
|
Concept/Terms |
Warfarin- Warfarin
- 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
|
Below are MeSH descriptors whose meaning is more general than "Warfarin".
Below are MeSH descriptors whose meaning is more specific than "Warfarin".
This graph shows the total number of publications written about "Warfarin" by people in this website by year, and whether "Warfarin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Warfarin" by people in Profiles.
-
Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithm. CPT Pharmacometrics Syst Pharmacol. 2022 01; 11(1):20-29.
-
Warfarin Anticoagulation and Fetal Central Nervous System Abnormalities: a Case Report. Clin Lab. 2021 Jun 01; 67(6).
-
Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis. Clin Pharmacol Ther. 2020 06; 107(6):1420-1433.
-
Validation of the MissionĀ® PTCoagulation Monitoring point-of-care device for the outpatient management of patients on long-term warfarin therapy. Int J Lab Hematol. 2018 08; 40(4):e71-e73.
-
Clinical outcomes in patients with isolated left ventricular noncompaction and heart failure. J Card Fail. 2014 Oct; 20(10):709-715.
-
Paediatric anticoagulation guidelines. S Afr Med J. 2012 Feb 23; 102(3 Pt 1):171-5.
-
Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population. Pharmacogenomics. 2011 Jul; 12(7):953-63.
-
Maintenance of warfarin therapy at an anticoagulation clinic. S Afr Med J. 2007 Dec; 97(12):1259-65.
-
At last--the end of the prothrombin index. S Afr Med J. 2007 Dec; 97(12):1271.
-
Anticoagulation in South Africa--a dangerous necessity. S Afr Med J. 2006 Aug; 96(8):694.